Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Pharmacovigilance Market: By Service Provider: In-House, Contract Outsourcing; By Type; By Product Life Cycle; By Process Flow; By Therapeutic Area; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis; Competitive Landscape; Industry Events and Developments

Global Pharmacovigilance Market Outlook

The global pharmacovigilance market stood at a value of more than USD 6.4 billion in 2021. The market is further expected to grow at a CAGR of 11.3% in the forecast period of 2022-2027 to attain over USD 12.2 billion by 2027.

 

Global Pharmacovigilance Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Growing Demand for Spontaneous Reporting to Bolster the Growth of the Pharmacovigilance

Based on type, the spontaneous reporting is anticipated to account for a significant share in the market and is likely to grow at a considerable growth rate during the forecast period. The growth of this segment can be attributed to the voluntary nature of the reporting, which is driven by the motivated, encouraged consumers, or healthcare professionals towards detection and countermeasures against the adverse effects of pharmaceutical drugs or medicines. In addition to this, the growing awareness among the people about the negative effects of certain medical drugs and strong medicines is likely to encourage the consumers towards taking countermeasures and propel the growth of the market.

Apart from this, the contract outsourcing segment is predicted to represent a significant share in the market in the following years due to trends surrounding the outsourcing of services owing to benefits such as proper risk management, resource flexibility, reduction of upfront investments, and fixed lower cost.

 

North America to Account for a Significant Share in the Market

The pharmacovigilance industry in North America is driven by the increasing use of medicines for the treatment of chronic diseases in the United States of America and Canada. The associated risks that come along with high consumption of medicines are likely to propel the demand for pharmacovigilance in the region. Over the forecast period, the favourable government regulations and drug authorities, such as the Food and Drug Administration (FDA), which are intended towards monitoring and collect data about the side effects of medical drugs are likely to provide impetus to the market. Hence, these factors are expected to augment the market growth in North America in the coming years.

 

Pharmacovigilance: Market Segmentation

Pharmacovigilance is defined as the branch of science that deals with the detection, assessment, understanding, and prevention of adverse effects related to pharmaceutical drugs. It focuses on examining and monitoring adverse drug reactions after medicinal products.

 

Global Pharmacovigilance Market  by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on service provider, the market is divided into:

  • In-House
  • Contract Outsourcing

The significant types of pharmacovigilance in the market are:

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring 
  • EHR Mining

By product life cycle, the industry is segmented into:

  • Pre-Clinical
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

On the basis of process flow, the market is segmented into:

  • Case Data Management            
    • Case Logging 
    • Case Data Analysis
    • Medical Reviewing and Reporting
  • Signal Detection
    • Adverse Event Logging
    • Adverse Event Analysis
    • Adverse Event Review and Reporting
  • Risk Management System 
    • Risk Evaluation System
    • Risk Mitigation System

The market, on the basis of therapeutic area, can be divided into:

  • Oncology
  • Neurology
  • Cardiology
  • Respiratory Systems
  • Others

The major end uses in the market include:

  • Pharmaceuticals
  • Biotechnology Companies
  • Medical Device Manufacturers 
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Pharmacovigilance Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Demand for Pharmacovigilance from the Pharmaceutical Sector to Boost the Market Growth

The pharmacovigilance industry is driven by the rising applications of the product in the pharmaceutical industry. The growing prevalence of chronic diseases, such as oncological diseases, diabetes, cardiovascular, and respiratory disorders, among others, have propelled the demand for medicines and medical drugs. This factor has encouraged the use of pharmacovigilance at a worldwide level. Research and development (R&D) activities directed at studying the ill-effects of medicines among the geriatric population and infants are likely to augment the market growth of pharmacovigilance over the forecast period. Therefore, the growing importance of mitigating the adverse effects of drugs is likely to boost the pharmacovigilance industry in the forecast period.

 

Key Industry Players in the Global Pharmacovigilance Market

The report gives a detailed analysis of the following key players in the global pharmacovigilance market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Accenture plc
  • Linical Americas
  • IQVIA
  • Cognizant
  • Laboratory Corporation of America Holdings
  • IBM Corporation
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical
and Forecast Market Analysis by Segment- Service Provider, Type, Product Life Cycle, Process Flow, Therapeutic Area, End Use, Region
Breakup by Service Provider In-House, Contract Outsourcing
Breakup by Type Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, HER Mining
Breakup by Product Life Cycle Pre-Clinical, Phase I, Phase II, Phase III, Phase IV
Breakup by Process Flow Case Data Management, Signal Detection, Risk Management System
Breakup by Therapeutic Area Oncology, Neurology, Cardiology, Respiratory Systems, Others
Breakup by End Use Pharmaceuticals, Biotechnology Companies, Medical Device Manufacturers, Others, Region
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Accenture plc, Linical Americas, IQVIA, Cognizant, Laboratory Corporation of America Holdings, IBM Corporation, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Pharmacovigilance Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Pharmacovigilance Historical Market (2017-2021) 
    8.3    Global Pharmacovigilance Market Forecast (2022-2027)
    8.4    Global Pharmacovigilance Market by Service Provider
        8.4.1    In-House
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Contract Outsourcing
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
    8.5    Global Pharmacovigilance Market by Type
        8.5.1    Spontaneous Reporting
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Intensified ADR Reporting
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Targeted Spontaneous Reporting
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Cohort Event Monitoring
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    HER Mining
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2017-2021)
            8.5.5.3    Forecast Trend (2022-2027)
    8.6    Global Pharmacovigilance Market by Product Life Cycle
        8.6.1    Pre-Clinical
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    Phase I
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Phase II
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Phase III
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2017-2021)
            8.6.4.3    Forecast Trend (2022-2027)
        8.6.5    Phase IV
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2017-2021)
            8.6.5.3    Forecast Trend (2022-2027)
    8.7    Global Pharmacovigilance Market by Process Flow
        8.7.1    Case Data Management
            8.7.1.1    Market Share
            8.7.1.2    Historical Trend (2017-2021)
            8.7.1.3    Forecast Trend (2022-2027)
            8.7.1.4    Breakup by Type
                8.7.1.4.1    Case Logging
                8.7.1.4.2    Case Data Analysis
                8.7.1.4.3    Medical Reviewing and Reporting
        8.7.2    Signal Detection
            8.7.2.1    Market Share
            8.7.2.2    Historical Trend (2017-2021)
            8.7.2.3    Forecast Trend (2022-2027)
            8.7.2.4    Breakup by Type
                8.7.2.4.1    Adverse Event Logging
                8.7.2.4.2    Adverse Event Analysis
                8.7.2.4.3    Adverse Event Review and Reporting
        8.7.3    Risk Management System
            8.7.3.1    Market Share
            8.7.3.2    Historical Trend (2017-2021)
            8.7.3.3    Forecast Trend (2022-2027)
            8.7.3.4    Breakup by Type
                8.7.3.4.1    Risk Evaluation System
                8.7.3.4.2    Risk Mitigation System
    8.8    Global Pharmacovigilance Market by Therapeutic Area
        8.8.1    Oncology
            8.8.1.1    Market Share
            8.8.1.2    Historical Trend (2017-2021)
            8.8.1.3    Forecast Trend (2022-2027)
        8.8.2    Neurology
            8.8.2.1    Market Share
            8.8.2.2    Historical Trend (2017-2021)
            8.8.2.3    Forecast Trend (2022-2027)
        8.8.3    Cardiology
            8.8.3.1    Market Share
            8.8.3.2    Historical Trend (2017-2021)
            8.8.3.3    Forecast Trend (2022-2027)
        8.8.4    Respiratory Systems
            8.8.4.1    Market Share
            8.8.4.2    Historical Trend (2017-2021)
            8.8.4.3    Forecast Trend (2022-2027)
        8.8.5    Others
    8.9    Global Pharmacovigilance Market by End Use
        8.9.1    Pharmaceuticals
            8.9.1.1    Market Share
            8.9.1.2    Historical Trend (2017-2021)
            8.9.1.3    Forecast Trend (2022-2027)
        8.9.2    Biotechnology Companies
            8.9.2.1    Market Share
            8.9.2.2    Historical Trend (2017-2021)
            8.9.2.3    Forecast Trend (2022-2027)
        8.9.3    Medical Device Manufacturers
            8.9.3.1    Market Share
            8.9.3.2    Historical Trend (2017-2021)
            8.9.3.3    Forecast Trend (2022-2027)
        8.9.4    Others
    8.10    Global Pharmacovigilance Market by Region
        8.10.1    Market Share
            8.10.1.1    North America
            8.10.1.2    Europe
            8.10.1.3    Asia Pacific
            8.10.1.4    Latin America
            8.10.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Accenture plc
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Linical Americas
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3    IQVIA
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Cognizant
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Laboratory Corporation of America Holdings
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    IBM Corporation
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Others
13    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Pharmacovigilance Market: Key Industry Highlights, 2017 and 2027
2.    Global Pharmacovigilance Historical Market: Breakup by Service Provider (USD Million), 2017-2021
3.    Global Pharmacovigilance Market Forecast: Breakup by Service Provider (USD Million), 2022-2027
4.    Global Pharmacovigilance Historical Market: Breakup by Type (USD Million), 2017-2021
5.    Global Pharmacovigilance Market Forecast: Breakup by Type (USD Million), 2022-2027
6.    Global Pharmacovigilance Historical Market: Breakup by Product Life Cycle (USD Million), 2017-2021
7.    Global Pharmacovigilance Market Forecast: Breakup by Product Life Cycle (USD Million), 2022-2027
8.    Global Pharmacovigilance Historical Market: Breakup by Process Flow (USD Million), 2017-2021
9.    Global Pharmacovigilance Market Forecast: Breakup by Process Flow (USD Million), 2022-2027
10.    Global Pharmacovigilance Historical Market: Breakup by Therapeutic Area (USD Million), 2017-2021
11.    Global Pharmacovigilance Market Forecast: Breakup by Therapeutic Area (USD Million), 2022-2027
12.    Global Pharmacovigilance Historical Market: Breakup by End Use (USD Million), 2017-2021
13.    Global Pharmacovigilance Market Forecast: Breakup by End Use (USD Million), 2022-2027
14.    Global Pharmacovigilance Historical Market: Breakup by Region (USD Million), 2017-2021
15.    Global Pharmacovigilance Market Forecast: Breakup by Region (USD Million), 2022-2027
16.    North America Pharmacovigilance Historical Market: Breakup by Country (USD Million), 2017-2021
17.    North America Pharmacovigilance Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Europe Pharmacovigilance Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Europe Pharmacovigilance Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Asia Pacific Pharmacovigilance Historical Market: Breakup by Country (USD Million), 2017-2021
21.    Asia Pacific Pharmacovigilance Market Forecast: Breakup by Country (USD Million), 2022-2027
22.    Latin America Pharmacovigilance Historical Market: Breakup by Country (USD Million), 2017-2021
23.    Latin America Pharmacovigilance Market Forecast: Breakup by Country (USD Million), 2022-2027
24.    Middle East and Africa Pharmacovigilance Historical Market: Breakup by Country (USD Million), 2017-2021
25.    Middle East and Africa Pharmacovigilance Market Forecast: Breakup by Country (USD Million), 2022-2027
26.    Global Pharmacovigilance Market Structure

Key Questions Answered in the Report

In 2021, the global pharmacovigilance market attained a value of more than USD 6.4 billion.

The market is projected to grow at a CAGR of 11.3% between 2022 and 2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach over USD 12.2 billion by 2027.

Factors such as the favourable government policies towards mitigating the risk of adverse effects of drugs, thriving pharmaceutical industry in the developed and emerging economies, and the growing prevalence of chronic diseases, are driving the market growth.

The market is expected to be determined by the growing R&D activities towards the drug development in the pharmaceutical industry, and the increasing number of outsourcing services over the forecast period.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major service providers of pharmacovigilance are in-house and contract outsourcing.

The various types of pharmacovigilance are spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and HER mining.

The market, based on product life cycles of pharmacovigilance, can be segmented into pre-clinical, phase I, phase II, phase III, and phase IV.

The significant process flows of pharmacovigilance are case data management, signal detection, and risk management system.

The different therapeutic areas of pharmacovigilance involve oncology, neurology, cardiology, and respiratory systems, among others.

The major end uses of pharmacovigilance are pharmaceuticals, biotechnology companies, and medical device manufacturers, among others.

The major players in the industry are Accenture plc, Linical Americas, IQVIA, Cognizant, Laboratory Corporation of America Holdings, and IBM Corporation, among others.

Analyst Review

The global pharmacovigilance market attained a value of more than USD 6.4 billion in 2021, driven by rising demand from the pharmaceutical sector. Aided by surging outsourcing services, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 11.3%. The market is projected to reach over USD 12.2 billion by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on service provider, the market can be divided into in-house and contract outsourcing. On the basis of type, the market can be classified into spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and HER mining. The market, based on product life cycle, can be categorised into pre-clinical, phase I, phase II, phase III, and phase IV. Based on process flow, the market can be categorised into case data management, signal detection, and risk management system. Based on therapeutic uses, the market can be categorised into oncology, neurology, cardiology, and respiratory systems, among others. On the basis of end use, the market can be segmented into pharmaceuticals, biotechnology companies, and medical device manufacturers, among others.  The major regional markets for pharmacovigilance are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Accenture plc, Linical Americas, IQVIA, Cognizant, Laboratory Corporation of America Holdings, and IBM Corporation, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER